HONG KONG – A Chinese study has for the first time provided preclinical proof of concept that the targeting of tyrosine protein 6 (PTK6), also known as breast tumor kinase (BRK), with a small-molecule kinase inhibitor may represent a promising new breast cancer treatment strategy.
HONG KONG – A Chinese study has for the first time provided preclinical proof of concept that the targeting of tyrosine protein 6 (PTK6), also known as breast tumor kinase (BRK), with a small-molecule kinase inhibitor may represent a promising new breast cancer treatment strategy.
HONG KONG – A University of Hong Kong (HKU) phase II trial has shown that a drug derived from an herb used in traditional Chinese medicine to treat acute myeloid leukemia (AML) has helped patients with an aggressive treatment-refractory form of AML to achieve remission.
HONG KONG – A University of Hong Kong (HKU) phase II trial has shown that a drug derived from an herb used in traditional Chinese medicine to treat acute myeloid leukemia (AML) has helped patients with an aggressive treatment-refractory form of AML to achieve remission.
HONG KONG – Treatment with low levels of carbon monoxide (CO) may offer a novel dual approach to treating traumatic brain injury (TBI), by promoting neurogenesis and preventing the death of pericytes, cells that play multiple roles in blood flow in the brain and the blood-brain barrier.
HONG KONG — Treatment with low levels of carbon monoxide (CO) may offer a novel dual approach to treating traumatic brain injury (TBI), by promoting neurogenesis and preventing the death of pericytes, cells that play multiple roles in blood flow in the brain and the blood-brain barrier.
HONG KONG – A structurally nanoengineered antimicrobial peptide polymer (SNAPP) showed great promise as an inexpensive but safe and effective antimicrobial, and may be a useful new weapon in the war against multidrug-resistant (MDR) gram-negative bacteria, an Australian study has found.
HONG KONG – A structurally nanoengineered antimicrobial peptide polymer (SNAPP) showed great promise as an inexpensive but safe and effective antimicrobial, and may be a useful new weapon in the war against multidrug-resistant (MDR) gram-negative bacteria, an Australian study has found.
HONG KONG – Retinal cells derived from the reprogrammed stem cells of one monkey have been transplanted into the eyes of others, without immune rejection and need for immunosuppressants, said researchers from the RIKEN Center for Developmental Biology (CDB) in Kobe, Japan.
